Hypertension is a common and serious complication after renal transplantation. It is an important risk factor for graft loss and morbidity and mortality of transplanted children. The etiology of posttransplant hypertension is multifactorial: native kidneys, immunosuppressive therapy, renal-graft artery stenosis, and chronic allograft nephropathy are the most common causes. Blood pressure (BP) in transplanted children should be measured not only by casual BP (CBP) measurement but also regularly by ambulatory BP monitoring (ABPM). The prevalence of posttransplant hypertension ranges between 60% and 90% depending on the method of BP measurement and definition. Left ventricular hypertrophy is a frequent type of end-organ damage in hypertensive children after transplantation (50-80%). All classes of antihypertensive drugs can be used in the treatment of posttransplant hypertension. Hypertension control in transplanted children is poor; only 20-50% of treated children reach normal BP. The reason for this poor control seems to be inadequate antihypertensive therapy, which can be improved by increasing the number of antihypertensive drugs. Improved hypertension control leads to improved long-term graft and patient survival in adults. In children, there is a great potential for antihypertensive treatment that could also result in improved graft and patient survival.

Department of Pediatrics and Transplantation Center University University Hospital Motol Charles University Prague 2nd School of Medicine Prague Czech Republic

Zobrazit více v PubMed

Midtvedt K, Neumayer HH. Management strategies for posttransplant hypertension. Transplantation. 2000;70(Suppl 11):SS64–SS69. PubMed

Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation - a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Pediatr Nephrol. 1994;8:570–573. PubMed

Sorof JM, Sullivan EK, Tejani A, Portman RJ. Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol. 1999;10:1324–1330. PubMed

Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7:158–165. PubMed

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RSC, Geddes CC, Jardine AG. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant. 2005;19:181–192. PubMed

Opelz G, Wujciak T, Ritz E, Collaborative Transplant Study Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998;53:217–222. PubMed

Mange KC, Gizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283:633–638. PubMed

Schwenger V, Zeier M, Ritz E. Hypertension after renal transplantation. Curr Hypertens Rep. 2001;5:434–439. PubMed

Mitsnefes MM, Omoloja A, McEnery PT. Short-term pediatric renal transplant survival: Blood pressure and allograft function. Pediatr Transplant. 2001;5:160–165. PubMed

Mitsnefes MM, Khoury PR, McEnery PT. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003;143:98–103. PubMed

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576. PubMed

Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni G, Alpert B. Hypertension in young patients after renal transplantation, ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens. 1998;11:497–501. PubMed

Mitsnefes MM, Portman RJ. Ambulatory blood pressure monitoring in pediatric renal transplantation. Pediatr Transplant. 2003;7:86–92. PubMed

Ferraris JR1, Ghezzi L, Waisman G, Krmar RT. ABPM vs. office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients. Pediatr Transplant. 2007;11:24–30. PubMed

Mitsnefes MM, Kimball TR, Daniels SR. Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol. 2003;18:145–149. PubMed

Jacobi J, Rockstroh J, John S, Schreiber M, Schlaich MP, Neumayer HH, Schmieder RE. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation. 2000;70:819–827. PubMed

Bald M, Bohm W, Feldhoff C, Bonzel KE. Home blood pressure self-measurement in children and adolescents with renal replacement therapy. Klin Padiatr. 2001;213:21–25. PubMed

Wühl E, Hadtstein C, Mehls O, Schaefer F, Escape Trial Group Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res. 2004;55:492–497. PubMed

Marquez-Contreras E, Martell-Claros N, Gil-Guillen V, de la Figuera-Von Wichmann M, Casado-Martinez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A, Compliance Group of the Spanish Society of Hypertension Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study. J Hypertens. 2006;24:169–175. PubMed

Nagasako SS, Nogueira PC, Machado PGP. Arterial hypertension following renal transplantation in children - a short-term study. Pediatr Nephrol. 2003;18:1270–1274. PubMed

Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Schärer K. Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol. 1997;11:23–26. PubMed

Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 1999;56:1566–1570. PubMed

Giordano U, Matteucci MC, Calzolari A, Turchetta A, Rizzoni G, Alpert BS. Ambulatory blood pressure monitoring in children with aortic coarctation and kidney transplantation. J Pediatr. 2000;136:520–523. PubMed

Sorof JM, Poffenbarger T, Portman R. Abnormal 24-hour blood pressure patterns in children after renal transplantation. Am J Kidney Dis. 2000;35:681–686. PubMed

Morgan H, Khan I, Hashmi A, Hebert D, McCrindle BW, Balfe JW. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol. 2001;16:843–847. PubMed

Serdaroglu E, Mir S, Berdelli A. Hypertension and ACE gene insertion/deletion polymorphism in pediatric renal transplant patients. Pediatr Transplant. 2005;9:612–617. PubMed

Seeman T, Dušek J, Vondrák K, Šimková E, Kreisinger J, Feber J, Janda J. Ambulatory blood pressure monitoring in children after renal transplantation. Transplant Proc. 2004;36:1355–1356. PubMed

Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Feber J, Dvorák P, Janda J. Control of hypertension in children after renal transplantation. Pediatr Transplant. 2006;10:316–322. PubMed

McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant. 2006;10:558–564. PubMed

Kim HC, Kwon JK, Park SB, Cho WH, Park CH. Hypertension in kidney transplantation recipients: effect on long-term renal allograft survival. Transplant Proc. 1998;30:3906–3907. PubMed

Ponticelli C, Montagnino G, Aroldi A, Angelini C, Braga M, Tarantino A. Hypertension after renal transplantation. Am J Kidney Dis. 1993;5(Suppl 2):73–78. PubMed

Vianello A, Mastrosimone S, Calconi G, Gatti PL, Calzavara P, Maresca MC. The role of hypertension as damaging factor for kidney grafts under cyclosporine therapy. Am J Kidney Dis. 1993;21(Suppl 1):79–83. PubMed

Seeman T, Palyzova D, Dusek J, Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr. 2005;147:366–371. PubMed

Morales JM. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int. 2002;62(Suppl):S81–S87. PubMed

Lipkin GW, Tucker B, Giles M, Raine AE. Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens. 1993;11:439–442. PubMed

Gordjani A, Offner G, Hoyer PF, Brodehl J. Hypertension after renal transplantation in patients treated with cyclosporine and azathioprine. Arch Dis Child. 1990;65:275–279. PubMed PMC

Tejani A. Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients. Nephron. 1983;34:73–78. PubMed

Budde K, Waiser J, Fritsche L. Hypertension in patients after renal transplantation. Transplant Proc. 1997;29:209–211. PubMed

Pérez Fontán M, Rodríguez-Carmona A, Garcia Falcón T, FernándezRivera C, Valdés F. Early immunological and nonimmunological predictors of arterial hypertension after renal transplantation. Am J Kidney Dis. 1999;33:21–25. PubMed

Curtis JJ, Diethelm AG, Jones P, Luke RG, Whelchel JD. Benefits of removal of native kidney in hypertension after renal transplantation. Lancet. 1985;2:739–742. PubMed

Vanrenterghem Y, Waer M, Christiaens MR, Michielsen P. Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporine. Leuven Collaborative Group for Transplantation. Transpl Int. 1992;5(Suppl 1):S35–S37. PubMed

El-Husseini AA, Foda MA, Shokeir AA, Shebab El-Din AB, Sobh MA, Ghoneim MA. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: A single center experience. Pediatr Transplant. 2005;9:763–769. PubMed

Kasiske BL, Ballantyne CM. Cardiovascular risk associated with immunosuppression in renal transplantation. Transplant Rev. 2002;16:1–21.

Inguli E, Tejani A, Markell M. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation. 1993;55:1029–1033. PubMed

Hocker B, John U, Plank C, Wuhl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tonshoff B. Successful withdrawal of steroids in pediatrics renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation. 2004;78:228–234. PubMed

Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O., Jr Continued superior outcome with modification and lengthened follow-up of a steroid-avoidance pilot with extended Daclizumab induction in pediatric renal transplantation. Transplantation. 2003;76:1331–1339. PubMed

Curtis JJ, Galla JH, Kotchen TA, Lucas B, McRoberts JW, Luke RG. Prevalence of hypertension in a renal transplant population on alternate-day steroid therapy. Clin Nephrol. 1976;5:123–127. PubMed

Broyer M, Guest G, Gagnadoux MF, Beurton D. Hypertension following renal transplantation in children. Pediatr Nephrol. 1987;1:16–21. PubMed

Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation. 1987;43:197–204. PubMed

Curtis JJ. Hypertension following kidney transplantation. Am J Kidney Dis. 1994;23:471–475. PubMed

Büscher R, Vester U, Wingen AM, Hoyer PF. Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatr Nephrol. 2004;19:1202–1211. PubMed

Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol. 2002;17:141–149. PubMed

Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS, FK506 Kidney Transplant Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation. 1997;63:977–983. PubMed

Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation. 2002;73:775–782. PubMed

Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomized multicentre study. The European Tacrolimus vs Ciclosporin-Microemulsion Renal Transplantation Study Group. Lancet. 2002;359:741–746. PubMed

Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL. Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens. 1989;2:341–348. PubMed

Fernández-Fresnedo G, Palomar R, Escallada R, Martin de Francisco AL, Cotorruelo JG, Zubimendi JA, Sanz de Castro S, Ruiz JC, Rodrigo E, Arias M. Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrol Dial Transplant. 2001;16(Suppl 1):105–109. PubMed

Warholm C, Wilczek H, Pettersson E. Hypertension two years after renal transplantation: causes and consequences. Transpl Int. 1995;8:286–292. PubMed

Sorof J, Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002;40:441–447. PubMed

Lurbe E, Alvarez V, Liao Y, Tacons J, Cooper R, Cremades B, Torro I, Redon J. The impact of obesity and body fat distribution on ambulatory blood pressure in children and adolescents. Am J Hypertens. 1998;11:418–424. PubMed

Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2005;115:352–356. PubMed

Meier-Kriesche HU, Vaghela M, Thambuganipalle R, Friedman G, Jacobs M, Kaplan B. The effect of body mass index on long-term renal allograft survival. Transplantation. 1999;68:1294–1297. PubMed

Moreso F, Seron D, Anunciada AI, Hueso M, Ramon JM, Fulladosa X, Gil-Vernet S, Alsina J, Grinyo JM. Recipients body surface area as a predictor of post transplant renal allograft evolution. Transplantation. 1998;65:671–676. PubMed

Fontaine E, Barthelemy Y, Gagnadoux MF, Cukier J, Broyer M, Beurton D. A review of 72 renal artery stenosis in a series of 715 kidney transplantation in children. Prog Urol. 1994;4:193–205. PubMed

Fung LC, McLorie GA, Khoury AR, Churchill BM. Donor aortic cuff reduces the rate of anastomotic arterial stenosis in pediatric renal transplantation. J Urol. 1995;154:909–913. PubMed

Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol. 2004;15:134–141. PubMed

Montagnino G, Tarantino A, Banfi G, Maccario M, Costamagna L, Ponticelli C. Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors. Transpl Int. 2000;13:166–168. PubMed

Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med. 1992;92:375–383. PubMed

Berber I, Aydin C, Yigit B, Kara VM, Yildar M, Duzyol C, Turkmen F, Titiz MI, Altaca G. Blood pressure and graft outcome in renal transplantation. Transplant Proc. 2005;37:997–998. PubMed

Akioka K, Takahara S, Ichikawa S, Yoshimura N, Akiyama T, Ohshima S. Factors predicting long-term graft survival after kidney transplantation: Multicenter study in Japan. World J Surg. 2005;29:249–256. PubMed

Seeman T, Šimková E, Kreisinger J, Vondrák K, Dušek J, Gilík J, Dvorák P, Janda J. Improved control of hypertension in children after renal transplantation: Results of a two-yr interventional trial. Pediatr Transplant. 2007;11:491–497. PubMed

Mitsnefes MM, Kimball TR, Border WL, Glascock BJ, Khoury PR, Daniels SR. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis. 2004;43:721–726. PubMed

Kitzmueller E, Vécsei A, Pichler J, Bohm M, Muller T, Vargha R, Csaicsich D, Aufricht C. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol. 2004;19:1385–1389. PubMed

Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS. Mortality and causes of death of end-stage renal diseases in children: a Dutch cohort study. Kidney Int. 2002;61:621–629. PubMed

Ruggenenti P, Perna A, Mosconi L, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int. 1993;43:706–711. PubMed

Curtis JJ. Treatment of hypertension in renal allograft patients: Does drug selection make a difference. Kidney Int. 1997;52(Suppl 63):S75–S77. PubMed

Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, Fauchald P, Holdaas H. Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation. 2001;72:107–111. PubMed

Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis. 2000;35:58–63. PubMed

Arbeiter K, Pichler A, Stemberger R, Mueller T, Ruffingshofer D, Vargha R, Balzar E, Aufricht C. ACE inhibition in the treatment of children after renal transplantation. Pediatr Nephrol. 2004;19:222–226. PubMed

Ruggenenti P, Perna A, Gheradi G, Gaspari F, Benigni R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet. 1998;352:1352–1356. PubMed

Tejani A, Sullivan EK. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2000;4:107–111. PubMed

Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JFM. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant. 2004;19:2852–2857. PubMed

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol. 2006;17:889–899. PubMed

Opelz G, Zeier M, Laux G, Morath C, Dohler B. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A Collaborative Transplant Study report. J Am Soc Nephrol. 2006;17:3257–3262. PubMed

Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH. ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients. Hypertension. 1999;33:862–868. PubMed

Calvino J, Lens XM, Romero R, Sánchez-Guisande D. Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant. 2000;15:82–86. PubMed

Task force on cardiovascular disease Special report from the National Kidney Foundation. Am J Kidney Dis. 1998;32(Suppl 3):1–121. PubMed

Flynn JT. Hypertension and future cardiovascular disease in pediatric renal transplant recipients. Pediatr Transplant. 2006;10:276–278. PubMed

Opelz G, Dohler B, Collaborative Transplant Study Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–2731. PubMed

Groothoff JW, Cransberg K, Offringa M, Van De Kar NJ, Lilien MR, Davin JC, Heymans JS. Long-term follow-up of renal transplantation in children: a Dutch cohort study. Transplantation. 2004;78:453–460. PubMed

Stricter cumulative ambulatory blood pressure control is associated with regression of left ventricular hypertrophy in patients after kidney transplantation

Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?

Management of proteinuria in the transplanted patient

Ambulatory blood pressure monitoring in pediatric renal transplantation